title: [Study of an antioxidant dietary supplement "Karinat" in patients with benign breast disease].
abstract: A randomized double blind placebo-controlled trial of efficiency of a dietary supplement "Karinat" in patients with benign breast disease was carried out. Karinat contains beta-carotene 2.5 mg, alpha-tocopherol 5 mg, ascorbic acid 30 mg and garlic powder 150 mg per one tablet. Out of 66 patients, 33 patients were given karinat, 33 were given placebo. The patients reccived a tablet of karinal or placebo twice a day during 6 months. Examinations of the patients included clinical estimation of symptoms of mastopathy and dysalgomenorrhea, breast sonography and mammography. It was found that karinat reduced the severity of mastalgia, premenstrual syndrome, dysmenorrhea and algomenorrhea and caused regression of palpable symptoms of the breast fibromatosis. On the whole karinat had positive action in 75.8% that was significantly greater by 45.5% as compared with placebo. Karinat may be useful for the treatment of patients with benign breast disease.
authors.forename: V G
authors.initials: VG
authors.lastname: Bespalov
authors.forename: N Iu
authors.initials: NIu
authors.lastname: Barash
authors.forename: O A
authors.initials: OA
authors.lastname: Ivanova
authors.forename: P I
authors.initials: PI
authors.lastname: Krzhivitskiĭ
authors.forename: V F
authors.initials: VF
authors.lastname: Semiglazov
authors.forename: V A
authors.initials: VA
authors.lastname: Aleksandrov
authors.forename: N A
authors.initials: NA
authors.lastname: Sobenin
authors.forename: A N
authors.initials: AN
authors.lastname: Orekhov
mesh_terms: D000328:Adult; D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use*; D001205:Ascorbic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D001941:Breast Diseases / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000517:prevention & control; D001943:Breast Neoplasms / Q000175:diagnosis / Q000517:prevention & control*; D003627:Data Interpretation, Statistical; D019587:Dietary Supplements; D004311:Double-Blind Method; D004412:Dysmenorrhea / Q000517:prevention & control; D005260:Female; D018226:Fibroadenoma / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans; D008327:Mammography; D010173:Palpation; D010919:Placebos; D011293:Premenstrual Syndrome / Q000517:prevention & control; D013997:Time Factors; D016896:Treatment Outcome; D016217:Ultrasonography, Mammary; D024502:alpha-Tocopherol / Q000008:administration & dosage / Q000627:therapeutic use*; D019207:beta Carotene / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000975:Antioxidants; D010919:Placebos; C484361:karinat; D019207:beta Carotene; D024502:alpha-Tocopherol; D001205:Ascorbic Acid